Henry Jemil Esber - Net Worth and Insider Trading
Henry Jemil Esber Net Worth
The estimated net worth of Henry Jemil Esber is at least $51,671 dollars as of 2024-09-20. Henry Jemil Esber is the Director of Nanomix Corp and owns about 13,000 shares of Nanomix Corp (NNMX) stock worth over $31,850. Henry Jemil Esber is also the Director of Innovus Pharmaceuticals Inc and owns about 952 shares of Innovus Pharmaceuticals Inc (INNV) stock worth over $19,821. Details can be seen in Henry Jemil Esber's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henry Jemil Esber has not made any transactions after 2017-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Henry Jemil Esber
Henry Jemil Esber Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry Jemil Esber owns 5 companies in total, including Innovus Pharmaceuticals Inc (INNV) , Nanomix Corp (NNMX) , and Seelos Therapeutics Inc (SEEL) among others .
Click here to see the complete history of Henry Jemil Esber’s form 4 insider trades.
Insider Ownership Summary of Henry Jemil Esber
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INNV | Innovus Pharmaceuticals Inc | 2019-07-01 | director |
| NNMX | Nanomix Corp | 2015-03-18 | director |
| SEEL | Seelos Therapeutics Inc | 2009-12-14 | director & EVP Pre-Clinical Business Dev. |
 | | 2006-11-17 | director |
| | 2012-01-25 | director |
Henry Jemil Esber Latest Holdings Summary
Henry Jemil Esber currently owns a total of 2 stocks. Among these stocks, Henry Jemil Esber owns 13,000 shares of Nanomix Corp (NNMX) as of March 18, 2015, with a value of $31,850 and a weighting of 61.64%. Henry Jemil Esber also owns 952 shares of Innovus Pharmaceuticals Inc (INNV) as of November 23, 2017, with a value of $19,821 and a weighting of 38.36%.
Latest Holdings of Henry Jemil Esber
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NNMX | Nanomix Corp | 2015-03-18 | 13,000 | 2.45 | 31,850 |
| INNV | Innovus Pharmaceuticals Inc | 2017-11-23 | 952 | 20.82 | 19,821 |
Holding Weightings of Henry Jemil Esber
Henry Jemil Esber Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry Jemil Esber has made a total of 0 transactions in Nanomix Corp (NNMX) over the past 5 years. The most-recent trade in Nanomix Corp is the acquisition of 9,000 shares on March 18, 2015, which cost Henry Jemil Esber around $1,800.
According to the SEC Form 4 filings, Henry Jemil Esber has made a total of 0 transactions in Innovus Pharmaceuticals Inc (INNV) over the past 5 years. The most-recent trade in Innovus Pharmaceuticals Inc is the acquisition of 952 shares on November 23, 2017, which cost Henry Jemil Esber around $9,000.
Insider Trading History of Henry Jemil Esber
- 1
Henry Jemil Esber Trading Performance
GuruFocus tracks the stock performance after each of Henry Jemil Esber's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry Jemil Esber is 24.71%. GuruFocus also compares Henry Jemil Esber's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry Jemil Esber within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Henry Jemil Esber's insider trading performs compared to the benchmark.
Performance of Henry Jemil Esber
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.72 | | | | | |
| Relative Return to S&P 500(%) | -10.95 | | | | | |
Henry Jemil Esber Ownership Network
Henry Jemil Esber Owned Company Details
What does Innovus Pharmaceuticals Inc do?
Who are the key executives at Innovus Pharmaceuticals Inc?
Henry Jemil Esber is the director of Innovus Pharmaceuticals Inc. Other key executives at Innovus Pharmaceuticals Inc include 10 percent owner Armistice Capital, Llc , 10 percent owner Armistice Capital Master Fund Ltd. , and 10 percent owner Steven Boyd .
Innovus Pharmaceuticals Inc (INNV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Innovus Pharmaceuticals Inc (INNV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovus Pharmaceuticals Inc (INNV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Innovus Pharmaceuticals Inc (INNV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Innovus Pharmaceuticals Inc Insider Transactions
Henry Jemil Esber Mailing Address
Above is the net worth, insider trading, and ownership report for Henry Jemil Esber. You might contact Henry Jemil Esber via mailing address: 38 Angell Brook Drive, West Boylston Ma 01853.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
